Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib prior to RFA for intermediate hepatocellular cancer
NCT00813293Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Jun 2009
- Primary completion
- Nov 2013
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by Beth Israel Deaconess Medical Center. Started Jun 2009; status: completed.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00813293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00813293.